JP2023029902A5 - - Google Patents

Download PDF

Info

Publication number
JP2023029902A5
JP2023029902A5 JP2022188982A JP2022188982A JP2023029902A5 JP 2023029902 A5 JP2023029902 A5 JP 2023029902A5 JP 2022188982 A JP2022188982 A JP 2022188982A JP 2022188982 A JP2022188982 A JP 2022188982A JP 2023029902 A5 JP2023029902 A5 JP 2023029902A5
Authority
JP
Japan
Prior art keywords
seq
iii
amino acid
variants
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022188982A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023029902A (ja
Filing date
Publication date
Priority claimed from GBGB1700557.0A external-priority patent/GB201700557D0/en
Application filed filed Critical
Publication of JP2023029902A publication Critical patent/JP2023029902A/ja
Publication of JP2023029902A5 publication Critical patent/JP2023029902A5/ja
Priority to JP2024196183A priority Critical patent/JP2025032107A/ja
Pending legal-status Critical Current

Links

JP2022188982A 2017-01-12 2022-11-28 結核菌シャペロニン60.1ペプチドおよびその使用 Pending JP2023029902A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024196183A JP2025032107A (ja) 2017-01-12 2024-11-08 結核菌シャペロニン60.1ペプチドおよびその使用

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1700557.0A GB201700557D0 (en) 2017-01-12 2017-01-12 Novel peptides
GB1700557.0 2017-01-12
PCT/GB2018/050072 WO2018130834A1 (en) 2017-01-12 2018-01-11 Mycobacteria tuberculosis chaperonin 60.1 peptides and uses thereof
JP2019538337A JP7252895B2 (ja) 2017-01-12 2018-01-11 結核菌シャペロニン60.1ペプチドおよびその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019538337A Division JP7252895B2 (ja) 2017-01-12 2018-01-11 結核菌シャペロニン60.1ペプチドおよびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024196183A Division JP2025032107A (ja) 2017-01-12 2024-11-08 結核菌シャペロニン60.1ペプチドおよびその使用

Publications (2)

Publication Number Publication Date
JP2023029902A JP2023029902A (ja) 2023-03-07
JP2023029902A5 true JP2023029902A5 (enExample) 2023-04-21

Family

ID=58463310

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019538337A Active JP7252895B2 (ja) 2017-01-12 2018-01-11 結核菌シャペロニン60.1ペプチドおよびその使用
JP2022188982A Pending JP2023029902A (ja) 2017-01-12 2022-11-28 結核菌シャペロニン60.1ペプチドおよびその使用
JP2024196183A Pending JP2025032107A (ja) 2017-01-12 2024-11-08 結核菌シャペロニン60.1ペプチドおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019538337A Active JP7252895B2 (ja) 2017-01-12 2018-01-11 結核菌シャペロニン60.1ペプチドおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024196183A Pending JP2025032107A (ja) 2017-01-12 2024-11-08 結核菌シャペロニン60.1ペプチドおよびその使用

Country Status (9)

Country Link
US (1) US11098090B2 (enExample)
EP (1) EP3568148B1 (enExample)
JP (3) JP7252895B2 (enExample)
CN (1) CN110381979A (enExample)
AU (1) AU2018208077B2 (enExample)
CA (1) CA3049353C (enExample)
ES (1) ES2970436T3 (enExample)
GB (1) GB201700557D0 (enExample)
WO (1) WO2018130834A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12331088B2 (en) 2017-01-12 2025-06-17 Revolo Biotherapeutics Limited Method for the treatment of a relapsing-remitting condition
GB201700555D0 (en) * 2017-01-12 2017-03-01 Peptinnovate Ltd Method for the treatment of a relapsing-remitting condition
US12358957B2 (en) 2017-01-12 2025-07-15 Revolo Biotherapeutics Limited Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity
GB201700557D0 (en) * 2017-01-12 2017-03-01 Peptinnovate Ltd Novel peptides
WO2023223015A1 (en) 2022-05-16 2023-11-23 Revolo Biotherapeutics Limited Methods and compositions for preventing or treating food allergies
US20240287781A1 (en) 2023-02-28 2024-08-29 Toto Ltd. Wall-mounted flush toilet
WO2024218571A1 (en) * 2023-04-18 2024-10-24 Revolo Biotherapeutics Limited Methods and compositions for preventing or treating eosinophilic esophagitis
WO2025037259A1 (en) 2023-08-15 2025-02-20 Revolo Biotherapeutics Limited Methods and compositions for preventing or treating severe asthma
WO2025255468A2 (en) 2024-06-06 2025-12-11 Miguel Guzman Subcutaneous formulation of a peptide derived from chaperonin 60.1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028122D0 (en) 2000-11-17 2001-01-03 St Georges Entpr Ltd Method
GB0226105D0 (en) * 2002-11-08 2002-12-18 St Georges S Entpr Ltd Pain relief agents
FR2858936A1 (fr) 2003-08-22 2005-02-25 Diatos Potentialisation de l'activation de prodrogues de haut poids moleculaire
WO2008033820A2 (en) 2006-09-11 2008-03-20 The Board Of Trustees Of The University Of Illinois Modifications of cupredoxin derived peptides and methods of use thereof
GB0803369D0 (en) * 2008-02-25 2008-04-02 Helperby Therapeutics Ltd Biological materials and uses thereof
CA2779730C (en) 2009-11-05 2019-04-30 University Of Virginia Patent Foundation Compositions and methods for detecting plectin-1 as a biomarker for cancer
GB201118201D0 (en) 2011-10-21 2011-12-07 Helperby Therapeutics Ltd Novel peptides
GB201700557D0 (en) * 2017-01-12 2017-03-01 Peptinnovate Ltd Novel peptides

Similar Documents

Publication Publication Date Title
JP2023029902A5 (enExample)
Arning et al. Mammalian splicing factor SF1 is encoded by variant cDNAs and binds to RNA.
JP2018171063A5 (enExample)
JP2009520463A5 (enExample)
AU756110B2 (en) Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
JP2009544333A5 (enExample)
Aimoto Contemporary methods for peptide and protein synthesis
JP2024028452A5 (enExample)
JP2023179752A5 (enExample)
CA2237845A1 (en) Collagen-like peptoid residue-containing structures
JP2008522954A5 (enExample)
JPWO2018234492A5 (enExample)
CN119013310A (zh) 具有改善的编辑精确度的突变的胞嘧啶脱氨酶
JP2006507328A5 (enExample)
JPWO2020230869A5 (enExample)
JPWO2020056127A5 (enExample)
Heim et al. The legumin gene family: a reconstructed Vicia faba legumin gene encoding a high-molecular-weight subunit is related to type B genes
KR100627935B1 (ko) 활성 성분을 운반하는데 사용된 폴리오마 바이러스의바이러스 단백질 2 또는 3의 단편
JP2023145672A5 (enExample)
JPWO2023190199A5 (enExample)
WO2024059862A3 (en) Fibroin peptides and protein fragments compositions
JP2010537984A (ja) ポリペプチドおよび蛋白質の化学合成のための方法および中間体
JPWO2019210055A5 (enExample)
JPWO2023012652A5 (enExample)
CN1041366A (zh) 具有t细胞抑制基因活性的肽的合成方法